GB0621830D0 - Inhibitors of p38 mitogen-activated protein kinase - Google Patents

Inhibitors of p38 mitogen-activated protein kinase

Info

Publication number
GB0621830D0
GB0621830D0 GBGB0621830.9A GB0621830A GB0621830D0 GB 0621830 D0 GB0621830 D0 GB 0621830D0 GB 0621830 A GB0621830 A GB 0621830A GB 0621830 D0 GB0621830 D0 GB 0621830D0
Authority
GB
United Kingdom
Prior art keywords
mitogen
inhibitors
protein kinase
activated protein
activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0621830.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chroma Therapeutics Ltd
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Priority to GBGB0621830.9A priority Critical patent/GB0621830D0/en
Publication of GB0621830D0 publication Critical patent/GB0621830D0/en
Priority to PCT/GB2007/004019 priority patent/WO2008053158A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0621830.9A 2006-11-02 2006-11-02 Inhibitors of p38 mitogen-activated protein kinase Ceased GB0621830D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0621830.9A GB0621830D0 (en) 2006-11-02 2006-11-02 Inhibitors of p38 mitogen-activated protein kinase
PCT/GB2007/004019 WO2008053158A1 (en) 2006-11-02 2007-10-22 Inhibitors of p38 mitogen-activated protein kinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0621830.9A GB0621830D0 (en) 2006-11-02 2006-11-02 Inhibitors of p38 mitogen-activated protein kinase

Publications (1)

Publication Number Publication Date
GB0621830D0 true GB0621830D0 (en) 2006-12-13

Family

ID=37547198

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0621830.9A Ceased GB0621830D0 (en) 2006-11-02 2006-11-02 Inhibitors of p38 mitogen-activated protein kinase

Country Status (2)

Country Link
GB (1) GB0621830D0 (en)
WO (1) WO2008053158A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006243000B2 (en) * 2005-05-05 2011-05-26 Macrophage Pharma Limited Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
JP5555186B2 (en) 2008-02-29 2014-07-23 クロマ セラピューティクス リミテッド p38 MAP kinase inhibitor
GB0811930D0 (en) 2008-06-30 2008-07-30 Imec Inter Uni Micro Electr Polymerisable compounds for making opto-electronic devices
EP2206712A1 (en) * 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
KR20130111968A (en) * 2010-06-22 2013-10-11 키에시 파르마슈티시 엣스. 피. 에이. Alkaloid aminoester derivatives and medicinal composition thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2404603A1 (en) * 2000-10-23 2012-01-11 Glaxosmithkline LLC Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases
EP1345603A4 (en) * 2000-12-20 2004-09-08 Merck & Co Inc (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
PE20100737A1 (en) * 2005-03-25 2010-11-27 Glaxo Group Ltd NEW COMPOUNDS
US20090137550A1 (en) * 2005-03-25 2009-05-28 Glaxo Group Limited Novel Compounds

Also Published As

Publication number Publication date
WO2008053158A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
HUS1500049I1 (en) Compounds and compositions as protein kinase inhibitors
HK1129298A1 (en) Dihydrodiazepines useful as inhibitors of protein kinases
HRP20141260T1 (en) Compounds and compositions as protein kinase inhibitors
IL206416A0 (en) Benzofuropyrimidinones as protein kinase inhibitors
IL194699A0 (en) Tetrahydropteridines useful as inhibitors of protein kinases
IL195864A0 (en) 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
PT2200436E (en) Substituted pyrimidinyl-amines as protein kinase inhibitors
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
PL2193133T3 (en) Imidazolothiadiazoles for use as protein kinase inhibitors
HK1146042A1 (en) Pyrimidine derivatives as protein kinase inhibitors
IL197724A0 (en) Compounds and compositions as protein kinase inhibitors
IL198315A0 (en) Compounds and compositions as protein kinase inhibitors
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
ZA200709269B (en) Protein kinase inhibitors
IL195005A0 (en) Inhibitors of akt (protein kinase b)
ZA200806871B (en) Dihydrodiazepines useful as inhibitors of protein kinases
GB0608837D0 (en) Inhibitors of MAP kinase
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
GB0621830D0 (en) Inhibitors of p38 mitogen-activated protein kinase
ZA200700751B (en) Azalndoles useful as inhibitors of protein kinases
GB0621978D0 (en) Inhibitors of p38 mitogen-activated protein kinase
ZA200810573B (en) Substituted 3-cyanopyridines as protein kinase inhibitors
ZA200809545B (en) Inhibitors of Akt (protein kinase B)
GB0621976D0 (en) Inhibitors of p38 mitogen-activated protein kinase
GB0621720D0 (en) Inhibitors of ikk- serine-threonine protein kinase

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)